Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJakob Lundgren, Johan Söderberg
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Pharmaceuticalization of society in context: theoretical, empirical and health dimensions
10.1177/0038038510369368 · 2010
Fatalities temporally associated with the ingestion of ibogaine
10.1111/j.1556-4029.2011.02008.x · 2012
The frontiers of new psychedelic therapies: a survey of sociological themes and issues
10.1111/soc4.12959 · 2022
Taking stock of integrative medicine: broadening biomedicine or co-option of complementary and alternative medicine?
10.5172/hesr.451.17.4.331 · 2008
Ibogaine therapy for addiction: consumer views from online fora
10.1016/j.drugpo.2020.102857 · 2020
Medicalization and pharmaceuticalization at the intersections: looking backward, sideways and forward
10.1016/j.socscimed.2012.04.002 · 2012
Ibogaine and subjective experience: transformative states and psychopharmacotherapy in the treatment of opioid use disorder
10.1080/02791072.2019.1598603 · 2019
The concept of medicalisation reassessed
10.1111/1467-9566.12538 · 2017
Magnesium–ibogaine therapy in veterans with traumatic brain injuries
2024
Interactional expertise as a third kind of knowledge
10.1023/b:phen.0000040824.89221.1a · 2004
Unresolved referenced work
2007
Tactics of legitimation in the psychedelic sciences: lessons for feminist sociology of knowledge
10.1177/0002764212454422 · 2012
Medicalisation, pharmaceuticalisation, or both? Exploring the medical management of sleeplessness as insomnia
10.1111/1467-9566.12820 · 2019
Case report: ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion
10.3389/fpain.2023.1256396 · 2023
Clinical guidelines for ibogaine-assisted detoxification
2015
Unresolved referenced work
Kept as external metadata until matched
The future of iboga: perspectives from central Africa
2020
Visions on iboga/ine: from the international community
2019
What if psychedelics' hallucinations are just a side effect?
2023
The sociology of traditional, complementary and alternative medicine
10.1111/soc4.12182 · 2014
18-Methoxycoronaridine (18-MC) and ibogaine: Comparison of antiaddictive efficacy, toxicity, and mechanisms of action
10.1111/j.1749-6632.2000.tb05211.x · 2006
Examination of the phenomenology of the ibogaine treatment experience: role of altered states of consciousness and psychedelic experiences
10.1080/02791072.2017.1290855 · 2017
Beyond scientific consensus: scientific counterpublics, countervailing industries, and competing research agendas
2014
Efficient and modular synthesis of ibogaine and related alkaloids
10.1038/s41557-024-01714-7 · 2025
Alternative medicine's encounter with laboratory science: the scientific construction of Korean medicine in a global age
10.1177/0306312707076600 · 2007
Thinking differently with Chinese medicine: ‘explanations’ and case studies for a postcolonial STS
10.1177/03063127221092180 · 2022
Ibogaine: revisiting an ancient alkaloid for modern opioid dependence
10.1080/10826084.2024.2403109 · 2025
How ‘alternative’ is CAM? Rethinking conventional dichotomies between biomedicine and complementary/alternative medicine
10.1177/1363459312447252 · 2013
Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders
10.1038/s44184-026-00185-7 · 2026
Complementary and alternative medicine: an overview
2002
The medicalisation of revolt: a sociological analysis of medical cannabis users
10.1111/j.1467-9566.2012.01476.x · 2013
Trump's psychedelic executive order: president expands access to psychoactive drugs
10.1136/bmj.s794 · 2026
Searching for a ‘new magical world’: the contradictions of CAM and new age therapies in the west
10.1080/13648470.2018.1544605 · 2020
A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment
10.1556/2054.01.2017.007 · 2017
Operationalizing legitimacy
10.1177/00031224221081379 · 2022
Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States
2022
The psychedelic renaissance: a case of outlaw user innovation in the pharmaceutical industry
2022
Risk management in a global market of alternative addiction care: a case study of the ibogaine medical subculture
10.1057/s41285-025-00220-1 · 2025
Medicalising the menace? The symbiotic convergence of medicine and law enforcement in the medicalisation of marijuana in Minnesota
10.1111/1467-9566.13513 · 2022
Unresolved referenced work
2014
The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance
10.1002/fhu2.70004 · doi-reference
The pharmaceuticalisation of society? A framework for analysis
10.1111/j.1467-9566.2011.01320.x · doi-reference
The concept of medicalisation reassessed: a response to joan busfield
10.1111/1467-9566.12576 · doi-reference
Active compounds and atoms of society: plants, bodies, minds and cultures in the work of Kenyan ethnobotanical knowledge
10.1177/0306312709104075 · doi-reference
Ibogaine therapy: a “Vast, Uncontrolled Experiment.”
10.1126/science.308.5720.345 · doi-reference
Theory construction in qualitative research: from grounded theory to abductive analysis
10.1177/0735275112457914 · doi-reference